Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02708680
Title Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In
Recruitment Unknown status
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Syndax Pharmaceuticals

triple-receptor negative breast cancer



Atezolizumab + Entinostat

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.